Opiant Pharmaceuticals Announces First Patient Dosed in
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking risk levels1 Trial is informed by...
Source: globenewswire.com
Stay updated with breaking news from Sequential Parallel Comparison Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking risk levels1 Trial is informed by...